RecallDepth
Class II Terminated

Anastrozole Tablets, USP, 1 mg, a) 30-count (NDC 68001-155-04) and 1000-count (NDC 68001-155-08) bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India For BluePoint Laboratories

Company
American Health Packaging
Recall Initiated
May 9, 2019
Posted
July 17, 2019
Recall Number
D-1467-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
375,921 bottles
Firm Location
Columbus, OH, United States

Reason for Recall

GMP Deviations: Potential cross contamination due to cleaning procedure failure.

Distribution

Nationwide USA

Lot / Code Info

Count, Lot, Expiry: [30-count bottle] Lots M711214, M711215, M711216, M711217, exp 8/31/2019; Lots M802198, M802199, exp 1/31/2020; Lots M805203, M805204, M805207, exp 3/31/2019; Lots M812455, exp 6/30/2020; Lot M815766, exp 9/30/2020; Lots M818633, M818634, exp 10/31/2020; Lots M819858, M819859, exp 11/30/2020 [1000-count bottle] Lot M711218, exp 8/31/2019; Lot M802197, exp 1/31/2020; Lots M805209, M805946, exp 3/31/2020; Lot M812456, exp 6/30/2020; Lots M815767, M818273, exp 9/30/2020; Lot M819857, exp 11/30/2020

More recalls by American Health Packaging

View all recalls by this company →

Other recent Class II Drug recalls